Please provide your email address to receive an email when new articles are posted on . Abnormal ECG findings were rare in elite female basketball players. These data may serve as a reference for ...

HeartBeam’s synthesised 12-lead electrocardiogram (ECG) has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias. In the study, the mean difference in ...

Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...

Research shows that a newly-developed wireless EKG patch is as accurate, if not more accurate, than results from traditional EKG machines. The device is known as the EKG Patch Solution. Worldwide, ...

SANTA CLARA, Calif., April 29, 2025--(BUSINESS WIRE)--HeartBeam, Inc., (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, ...

Sept. 24 (UPI) --Changes in heart function observed on electrocardiograms of patients hospitalized with COVID-19 or influenza can help predict a time frame for worsening health, a study published ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Peer-reviewed medical journal JAMA Cardiology today published a study ...

The electrocardiogram test commonly given to people suspected of having cramping chest pains from angina have limited value when it comes to predicting future heart problems, a new study suggests.

SANTA CLARA, Calif. – HeartBeam, Inc. (NASDAQ: BEAT), a pioneer in cardiac care technology with a market capitalization of $65.76 million, has announced positive results from its VALID-ECG pivotal ...

The Apple Watch's electrocardiogram feature, along with other health indicators, can act as a basic stress detector. A new study shows the device is useful for indicating stress due to a range of ...

It’s a big week for Google’s wearable plans. Following news that it’s paying $40 million for Fossil technology, parent company Alphabet announced it’s obtained FDA clearance for its electrocardiogram ...